<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00872612</url>
  </required_header>
  <id_info>
    <org_study_id>LUMC-GRANULOMA</org_study_id>
    <nct_id>NCT00872612</nct_id>
  </id_info>
  <brief_title>Trial for the Diagnosis of Sarcoidosis</brief_title>
  <acronym>GRANULOMA</acronym>
  <official_title>Endosonography (EUS and EBUS) vs Conventional Bronchoscopy for the Diagnosis of Sarcoidosis: a Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized study investigates two different diagnostic strategies for patients with
      suspected pulmonary sarcoidosis stage I/II.

      The objective is to assess the role of endosonography (EBUS/ EUS - FNA) in demonstrating
      non-caseating granulomas in comparison with conventional bronchoscopy (TBLB + EBB).

      Also the researchers investigate the additional value of BAL, in relation to endosonography
      and conventional bronchoscopy (TBLB + EBB), in diagnosing sarcoidosis.

      Thirdly the researchers aim to assess the rate of complications in both the endosonography
      and conventional bronchoscopic workup.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sarcoidosis is the most prevalent interstitial lung disease in Western-Europe and the US. The
      disease is most prevalent in young adults. To set the final diagnosis of sarcoidosis, the
      following parameters need to be present:

        1. A clinical and radiological suspicion of sarcoidosis stage I/II.

        2. A tissue diagnosis of disease-specific non-caseating granulomas.

        3. Exclusion of possible alternative diagnoses as lung cancer or tuberculosis.

      Nowadays, a bronchoscopy with lung biopsies is advised to set a tissue diagnosis of
      sarcoidosis. However, these biopsies are only diagnostic in 70% of the procedures and they
      are associated with a 3% risk of coughing up blood and a 4% risk of a lung collapse.

      Since recently, a new diagnostic procedure has come available. This procedure,
      endo-sonography, makes it possible to biopsy lymph nodes in the chest under direct
      visualization and has a diagnostic accuracy of 85%. The associated risk of complications
      appears to be small (&lt;1%)

      We consider the current standard for the diagnostics of sarcoidosis to be outdated,
      considering the clinical availability of endo-sonography. We expect that endo-sonography is
      more frequent diagnostic for a tissue diagnosis of sarcoidosis.

      Also we hypothesize that this technique is safer and more preferred by patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The role of endosonography (EBUS/ EUS - FNA) in demonstrating non-caseating granulomas in comparison with conventional bronchoscopy (TBLB + EBB)</measure>
    <time_frame>within a week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of complications of both the endosonography and conventional bronchoscopic workup</measure>
    <time_frame>within 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The additional value of BAL, in relation to endosonography and conventional bronchoscopy (TBLB + EBB), in diagnosing sarcoidosis</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of patient preference for both the endosonographic and conventional bronchoscopic work-up.</measure>
    <time_frame>within a week</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">304</enrollment>
  <condition>Sarcoidosis</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endosonography arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional bronchoscopy arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EUS-FNA/EBUS-TBNA + BAL</intervention_name>
    <description>EUS-FNA = Endoscopic Ultrasound guided fine needle aspiration of mediastinal lymph nodes.
EBUS-TBNA = Endobronchial Ultrasound guided transbronchial needle aspiration of mediastinal and hilar lymph nodes.
BAL = bronchoalveolar lavage</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBB + TBLB + BAL</intervention_name>
    <description>EBB = Endobronchial biopsy TBLB = Transbronchial biopsy BAL = Bronchoalveolar lavage</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with suspected pulmonary sarcoidosis stage I/ II

          -  Age &gt; 18 years

          -  Both males and females

          -  Written informed consent is obtained.

        Exclusion Criteria:

          -  Patients with obvious other organ involvement of sarcoidosis where a simple diagnostic
             biopsy to assess granulomas can be performed.

          -  Löfgren's syndrome

          -  Inability to undergo fiberbronchoscopy, EBUS or EUS (e.g. respiratory insufficiency,
             esophageal stenosis

          -  Contraindications for a lung or nodal biopsy (e.g. coagulopathy, thrombocytopenia)

          -  Pregnancy

          -  Inability to obtain informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M B von Bartheld, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Pulmonary Department, Leiden University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J T Annema, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pulmonary Department, Leiden University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>K F Rabe, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pulmonary Department, Leiden University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gentofte Hospital Copenhagen</name>
      <address>
        <city>Hellerup</city>
        <state>Copenhagen</state>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thoraxklinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Grosshansdorf</name>
      <address>
        <city>Grosshansdorf</city>
        <state>Schleswig-Holstein</state>
        <zip>22927</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rijnstaete Ziekenhuis</name>
      <address>
        <city>Arnhem</city>
        <state>Gelderland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radboud Universitair Medisch Centrum</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <state>Noord-Brabant</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Haaglanden</name>
      <address>
        <city>Den Haag</city>
        <state>Zuid-Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulmonary Department, Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <state>Zuid-Holland</state>
        <zip>2300 RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medisch Centrum</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid-Holland</state>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Franciscus Ziekenhuis</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid-Holland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University hospital Krakow, J.P. II</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sokołowski Pulmonary Hospital</name>
      <address>
        <city>Zakopane</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chelsea and Westminster hospital</name>
      <address>
        <city>London</city>
        <zip>SW10 9NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999 Oct;14(4):735-7. Review.</citation>
    <PMID>10573213</PMID>
  </reference>
  <reference>
    <citation>Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007 Nov 22;357(21):2153-65. Review.</citation>
    <PMID>18032765</PMID>
  </reference>
  <reference>
    <citation>Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest. 1993 Aug;104(2):352-61.</citation>
    <PMID>8339618</PMID>
  </reference>
  <reference>
    <citation>Kantrow SP, Meyer KC, Kidd P, Raghu G. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J. 1997 Dec;10(12):2716-21.</citation>
    <PMID>9493649</PMID>
  </reference>
  <reference>
    <citation>Annema JT, Veseliç M, Rabe KF. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of sarcoidosis. Eur Respir J. 2005 Mar;25(3):405-9.</citation>
    <PMID>15738281</PMID>
  </reference>
  <reference>
    <citation>Garwood S, Judson MA, Silvestri G, Hoda R, Fraig M, Doelken P. Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest. 2007 Oct;132(4):1298-304. Epub 2007 Sep 21.</citation>
    <PMID>17890467</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2009</study_first_submitted>
  <study_first_submitted_qc>March 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2009</study_first_posted>
  <last_update_submitted>December 4, 2015</last_update_submitted>
  <last_update_submitted_qc>December 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Leiden University Medical Center</investigator_affiliation>
    <investigator_full_name>M.B. von Bartheld</investigator_full_name>
    <investigator_title>MB von Bartheld, MSc. PhD Student</investigator_title>
  </responsible_party>
  <keyword>Sarcoidosis</keyword>
  <keyword>Diagnosis</keyword>
  <keyword>Non-caseating granulomas</keyword>
  <keyword>BAL</keyword>
  <keyword>EUS-FNA</keyword>
  <keyword>EBUS-TBNA</keyword>
  <keyword>TBLB</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoidosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

